Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 85

Results For "ED"

8078 News Found

Aarti Drugs Q2 FY24 consolidated net profit drops QOQ to Rs. 39.59 Cr
News | October 21, 2023

Aarti Drugs Q2 FY24 consolidated net profit drops QOQ to Rs. 39.59 Cr

Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023


Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr
News | October 21, 2023

Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr

Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023


Global Hand Washing Day: Sir HN Reliance Foundation Hospital initiates awareness campaign for underprivileged students in Mumbai
News | October 20, 2023

Global Hand Washing Day: Sir HN Reliance Foundation Hospital initiates awareness campaign for underprivileged students in Mumbai

hey were educated about the 7- step hand-washing technique trainings


Granules India receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules
Drug Approval | October 20, 2023

Granules India receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules

Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)


Need to include ASMD as a notified condition in the National Policy for rare diseases
Policy | October 20, 2023

Need to include ASMD as a notified condition in the National Policy for rare diseases

ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another


Shilpa Medicare Unit IV, Jadcherla has cleared TGA, Australia GMP inspection
Drug Approval | October 18, 2023

Shilpa Medicare Unit IV, Jadcherla has cleared TGA, Australia GMP inspection

This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years


Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site
News | October 17, 2023

Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site

Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening


Satish Pandurang Samant appointed CEO of Vineet Laboratories
People | October 16, 2023

Satish Pandurang Samant appointed CEO of Vineet Laboratories

He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr


Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
News | October 16, 2023

Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines

Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug


Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations
Drug Approval | October 14, 2023

Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations

The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally